Sandercock PA - Search Results

1

Blood pressure and clinical outcomes in the International Stroke Trial.

Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA; IST Collaborative Group. Leonardi-Bee J, et al. Among authors: sandercock pa. Stroke. 2002 May;33(5):1315-20. doi: 10.1161/01.str.0000014509.11540.66. Stroke. 2002. PMID: 11988609 Clinical Trial.

2

Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review).

Counsell C, Sandercock P. Counsell C, et al. Stroke. 2002 Jul;33(7):1925-6. doi: 10.1161/01.str.0000018820.99077.46. Stroke. 2002. PMID: 12105377 No abstract available.

3

Full heparin anticoagulation should not be used in acute ischemic stroke.

Sandercock P. Sandercock P. Stroke. 2003 Jan;34(1):231-2. doi: 10.1161/01.str.0000047037.38062.24. Stroke. 2003. PMID: 12511780 No abstract available.

4

In-hospital care pathways for stroke: a Cochrane systematic review.

Kwan J, Sandercock P. Kwan J, et al. Stroke. 2003 Feb;34(2):587-8. doi: 10.1161/01.str.0000054673.28010.1b. Stroke. 2003. PMID: 12574581 Review. No abstract available.

5

Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?

Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Wardlaw JM, et al. Among authors: sandercock pa. Stroke. 2003 Mar;34(3):806-12. doi: 10.1161/01.STR.0000058480.77236.B3. Epub 2003 Feb 27. Stroke. 2003. PMID: 12624314 Review.

6

Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis.

Wardlaw JM, Sandercock PA, Berge E. Wardlaw JM, et al. Among authors: sandercock pa. Stroke. 2003 Jun;34(6):1437-42. doi: 10.1161/01.STR.0000072513.72262.7E. Epub 2003 May 1. Stroke. 2003. PMID: 12730560

7

Anticoagulants versus antiplatelet agents for acute ischemic stroke.

Hankey GJ, Berge E, Sandercock P. Hankey GJ, et al. Stroke. 2003 Jun;34(6):1571-2. doi: 10.1161/01.STR.0000074551.42683.98. Epub 2003 May 22. Stroke. 2003. PMID: 12764231 Review. No abstract available.

8

Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs.

Sandercock P, Berge E, Dennis M, Forbes J, Hand P, Kwan J, Lewis S, Lindley R, Neilson A, Wardlaw J. Sandercock P, et al. Stroke. 2004 Jun;35(6):1490-7. doi: 10.1161/01.STR.0000126871.98801.6E. Epub 2004 Apr 22. Stroke. 2004. PMID: 15105519

9

Immediate computed tomography scanning of acute stroke is cost-effective and improves quality of life.

Wardlaw JM, Seymour J, Cairns J, Keir S, Lewis S, Sandercock P. Wardlaw JM, et al. Stroke. 2004 Nov;35(11):2477-83. doi: 10.1161/01.STR.0000143453.78005.44. Epub 2004 Sep 30. Stroke. 2004. PMID: 15459431

10

Impact of stroke syndrome and stroke severity on the process of consent in the Third International Stroke Trial.

Kane I, Lindley R, Lewis S, Sandercock P; IST-3 Collaborative Group. Kane I, et al. Cerebrovasc Dis. 2006;21(5-6):348-52. doi: 10.1159/000091541. Epub 2006 Feb 15. Cerebrovasc Dis. 2006. PMID: 16490945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

311 results

Search Page

Filters